Bioniche specializes in developing and implementing international programs for training health care professionals who serve as investigators in clinical research. The company leverages its training expertise and an array of educational tools, including multimedia and live meetings, to deliver specialized support programs for clinical investigators and study personnel. Bioniche will remain in McLean, VA and will join UBC's Training and Education Group.
UBC delivers evidence-based services to demonstrate the medical and economic value of pharmaceuticals, biotechnology, and medical devices to health care providers, consumers, regulators and payers. The company leverages its unique suite of scientific capabilities, operational expertise, and data resources to demonstrate product effectiveness, minimize safety risks, document economic value, and secure appropriate third-party payment for medicines and medical devices.
The acquisition of Bioniche reinforces UBC's position as the industry leader in the development and implementation of training and education programs to support clinical research and product commercialization. UBC believes that rigorously applied training and education programs are a critical factor in the collection of robust, credible scientific evidence to support product value propositions. The company began building its training and education practice with the acquisition of PharmaStar LLC in October, 2004.
"Widely recognized as a pioneer in the growing field of investigator training and patient education, UBC is constantly seeking new ways to enhance our offerings to clients," said Catherine Spear, Group President, UBC Training & Education Group. "With the addition of Bioniche, we expand our team of scientific experts, advance our existing education practice, and continue our commitment to delivering leading-edge training and education solutions to support clinical research and product commercialization."
"Joining with United BioSource opens up a new world of opportunity for our company and our clients," said Dr. David G. Daniel, President and Chief Medical Officer, Bioniche Global Learning. "UBC offers expansive resources that will allow us to both attract new clients and enhance service to our existing clients."
"With Bioniche, UBC becomes the undisputed market leader in training and educational support for pharmaceutical and biotechnology product development," said Ethan Leder, CEO of UBC. "This represents an important milestone on our path toward building the first dedicated provider of evidence-based solutions for the pharmaceutical, biotechnology, and medical device industries."
The addition of Bioniche is the latest in a series of acquisitions announced since UBC raised $153 million in equity capital from a syndicate of leading private equity firms.
About United BioSource Corporation
United BioSource Corporation (UBC) delivers scientific evidence to demonstrate the value of pharmaceuticals, biotechnology, and medical devices. UBC's global operations are managed by research scientists and industry experts in offices throughout North America and Europe. The company is headquartered in Bethesda, Maryland. For more information, please visit http://www.unitedbiosource.com.
About Bioniche Global Learning LLC
Bioniche Global Learning provides domestic and international rater training and other clinical trial and CME related educational services to the pharmaceutical and biotechnology industries. The Company specializes in psychiatry and other central nervous system diseases and is based in McLean, Virginia, with satellite offices throughout the United States and in Canada. For more information about Bioniche Global Learning, call 703.556.3345.
Source: United BioSource Corporation
